Best-in-class, synthetic, absorbable gel for use as an adjunct in lumbar spine surgery for the reduction of leg pain and neurological symptoms now available in the United States. SAN LUIS OBISPO, Calif., Nov. 5, 2025 /PRNewswire/ -- Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention with the … [Read more...] about Fziomed Initiates Commercialization of Oxiplex Gel in the United States
2025
4WEB Medical Ushers in the Era of Therapeutic Implant Technology
FRISCO, Texas, Nov. 5, 2025 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary TRUSS Implant Technology™, announced the publication of a study conducted at the McKay Orthopaedic Research Laboratory, Center for Musculoskeletal Disorders at the University of Pennsylvania. The … [Read more...] about 4WEB Medical Ushers in the Era of Therapeutic Implant Technology
Globus Medical Recognized by TIME as One of America’s Growth Leaders
Globus Medical has been recognized by TIME as one of America’s Growth Leaders, ranking #134 among the Top 500 Public Companies in the United States. This honor places the company among the top performers in the MedTech sector, standing out for its sustained growth, financial strength, and the dedication of its global team. Founded in 2003 and headquartered in Audubon, … [Read more...] about Globus Medical Recognized by TIME as One of America’s Growth Leaders
Orthofix Reports Third Quarter 2025 Financial Results
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within … [Read more...] about Orthofix Reports Third Quarter 2025 Financial Results
SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States
Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board now includes four North American surgeons and is set up to support the Company's expansion in the world's largest spinal market. DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory … [Read more...] about SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States
Astura Medical Receives FDA 510(k) Clearance for the Masada S2AI System
Astura Medical is proud to announce FDA 510(k) clearance of the Masada Sacral-Alar-Iliac (S2AI) System, the latest addition to our Masada Modular Posterior Fixation platform.Designed to provide sacroiliac joint fixation and fusion, the Masada S2AI System integrates seamlessly with the full Masada implant and instrumentation platform — offering surgeons the flexibility to extend … [Read more...] about Astura Medical Receives FDA 510(k) Clearance for the Masada S2AI System
Snke Unveils SnkeXR, the First Medical Grade, Open Platform AR Glasses for Healthcare
Augmented Reality Glasses Purpose-Built for the Medical Technology Industry MUNICH and the MDIC XR Summit HYATTVILLE, Md., – November 3, 2025 – Snke OS GmbH has announced the unveiling of SnkeXR, the first medical grade, open platform AR glasses purpose-built for the medical technology industry. The product will debut November 4 and 5 at the Medical Device Innovation … [Read more...] about Snke Unveils SnkeXR, the First Medical Grade, Open Platform AR Glasses for Healthcare
Can a Spine Sales Rep Be as Crucial as the Implant Itself?
I know what I’m about to say may sound unusual, and many of you might not agree at first. But I’m also sure that everyone who truly knows this market will understand exactly what I mean.In the spine implant industry, the role of the sales representative is quite unique. Unlike in other fields, surgeons do not “buy” implants in the traditional sense. Their choice depends not … [Read more...] about Can a Spine Sales Rep Be as Crucial as the Implant Itself?
Former Globus Medical CEO Dave Demski Joins Proprio as Advisor to Accelerate Data-Led Surgical Intelligence
Seattle, WA — 10/30/25 — Proprio, the surgical technology company pioneering real-time, AI-powered surgical intelligence, today announced that medtech leader Dave Demski, former CEO of Globus Medical, has joined the company as a Senior Strategic Advisor. Demski brings more than two decades of experience building one of the most successful platform companies in medtech. … [Read more...] about Former Globus Medical CEO Dave Demski Joins Proprio as Advisor to Accelerate Data-Led Surgical Intelligence
ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights. Recent Highlights “I’m eXtremely proud of the entire ATEC team for delivering … [Read more...] about ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance
Dr. Kingsley R. Chin Attends ForbesBLK Summit 2025 as VIP Guest to Hear Robert F. Smith and Stephen A. Smith — Aligns KIC Ventures’ Spine HealthTech Vision with Vista Equity’s Value-Building Model
At the ForbesBLK Summit in Atlanta, Dr. Chin and Executive Council member Taylor Headley represented KIC Ventures among top Black leaders driving enterprise value and innovation across industries. ATLANTA, Oct. 29, 2025 /PRNewswire/ -- Dr. Kingsley R. Chin, orthopedic spinal surgeon, CEO, and Founder of KIC Ventures, attended the ForbesBLK Summit 2025 in … [Read more...] about Dr. Kingsley R. Chin Attends ForbesBLK Summit 2025 as VIP Guest to Hear Robert F. Smith and Stephen A. Smith — Aligns KIC Ventures’ Spine HealthTech Vision with Vista Equity’s Value-Building Model
DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
Salt Lake City, UT — October 23, 2025 — DiscGenics, Inc., a privately held, late-stage clinical biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the publication of pioneering research demonstrating the first successful creation of … [Read more...] about DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
Introducing PorOssity™: Additive Surgical’s Flagship Range of Spine Implants
At Additive Surgical, we’ve reimagined what a spinal implant can be. After more than four years of intensive research and development, we are proud to introduce PorOssity™, our flagship range of spine implants that redefines the relationship between technology, biology, and clinical performance. A New Era in Spinal Implant Design PorOssity™ embodies a major leap forward … [Read more...] about Introducing PorOssity™: Additive Surgical’s Flagship Range of Spine Implants
Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
WEST CHESTER, Pa., Oct. 28, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of over $32 million in … [Read more...] about Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
What If a Bridge Could Inspire the Next Breakthrough in Spinal Implants?
An idea born from bridge safety monitoring may soon transform medicine. At the University of Pittsburgh, a team of civil engineers and neurosurgeons is developing the first self-powered spinal implant capable of sending real-time data from inside the body. Professors Amir Alavi, Nitin Agarwal, and D. Kojo Hamilton recently received a $352,000 grant from the National … [Read more...] about What If a Bridge Could Inspire the Next Breakthrough in Spinal Implants?
Aurora Spine Launches New Biologics Portfolio
CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of … [Read more...] about Aurora Spine Launches New Biologics Portfolio
Beyond Sales: How Can Distributors Redefine Their Value in Spine Care? Do They Still Have a Future?
Some thoughts on distributors and their current role.... Markets evolve over time, and the spinal implant industry is no exception. Over the past three decades, it has transformed from being dominated by a few companies—such as Sofamor Danek, Acromed, Synthes, and Aesculap—offering a limited range of products, to a highly diversified and competitive field. What once … [Read more...] about Beyond Sales: How Can Distributors Redefine Their Value in Spine Care? Do They Still Have a Future?
Why Lumbar Artificial Disc Replacements Are Poised to Make a Comeback?
Back in the early 2000s, lumbar artificial disc replacements were introduced as a fresh alternative for people dealing with degenerative spine problems. Instead of locking the vertebrae together through fusion, these implants aimed to keep the spine moving naturally, reduce strain on nearby segments, and help patients get back to normal life.Over time, though, the initial … [Read more...] about Why Lumbar Artificial Disc Replacements Are Poised to Make a Comeback?
Intrinsic Therapeutics Announces that AMA Released CPT 2026 Code Set Including New CPT Code 63032 Describing Bone-Anchored Annular Closure, Effective January 1, 2026
BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new Category I CPT® code, 63032, for bone-anchored annular closure, effective January 1, 2026. This new add-on CPT code specifically describes the adjunctive … [Read more...] about Intrinsic Therapeutics Announces that AMA Released CPT 2026 Code Set Including New CPT Code 63032 Describing Bone-Anchored Annular Closure, Effective January 1, 2026